Scarlet Therapeutics: Funding, Investors & Team (Oct 2026)
Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform.
Scarlet Therapeutics has raised $4.4M across 2 funding rounds on record, the most recent a Seed of $4.4M announced in May 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Scarlet Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
Scarlet Therapeutics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Scarlet Therapeutics announced a Seed in May 2023; the amount was not disclosed.
3 years later, a Seed of $4.4M was announced in May 2026.
Scarlet Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Scarlet Therapeutics Funding Compared to Other Biotechnology Startups
Scarlet Therapeutics' latest round of $4.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Scarlet Therapeutics in Biotechnology and Bristol
Companies Similar to Scarlet Therapeutics
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Scarlet Therapeutics Funding FAQs
What does Scarlet Therapeutics do?
Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform.
How much funding has Scarlet Therapeutics raised?
Scarlet Therapeutics has raised $4.4M across 2 rounds on record. The most recent is a Seed of $4.4M announced in May 2026.
When did Scarlet Therapeutics last raise funding?
Scarlet Therapeutics' most recent funding round on record is a Seed of $4.4M, announced in May 2026.
Who founded Scarlet Therapeutics?
FundedIQ lists Alistair Irvine (Founder) at Scarlet Therapeutics.
Where is Scarlet Therapeutics headquartered?
Scarlet Therapeutics is based in Bristol, Virginia, United Kingdom.
How many employees does Scarlet Therapeutics have?
Scarlet Therapeutics is in the 1-10 employee band.
How does Scarlet Therapeutics' funding compare to other Biotechnology startups?
Scarlet Therapeutics' latest round of $4.4M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Scarlet Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Scarlet Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.